Funding and Valuation - Whoop has closed a $575 million Series G funding round at a valuation of $10.1 billion, nearly tripling its last reported valuation of $3.6 billion [1] - The funding round was led by Collaborative Fund and included participation from various sovereign wealth funds, health institutions, and notable athletes [2] Financial Performance - Since its founding, Whoop has raised approximately $900 million in total [3] - The company reported a bookings run rate of $1.1 billion, reflecting a 103% year-over-year increase [4] Strategic Focus - The partnership with Abbott signals a broader push into health and medical capabilities, with more announcements expected [3] - Future capital will be directed towards talent acquisition, marketing, R&D investment, and international expansion [5] IPO Considerations - There is speculation about a potential IPO, with the company preparing for public company requirements, though no imminent plans have been confirmed [6][7]

Funding and Valuation - Whoop raised $575 million in Series G funding at a valuation of $10.1 billion, positioning itself as a significant player in the wearable device market [1] - The funding round was led by Collaborative Fund and included participation from notable investors such as Qatar Investment Authority, Abbott, and Mayo Clinic [2] - This capital raise allows Whoop to strengthen its balance sheet and is expected to be the last private round of financing before an IPO [2] Business Performance - Whoop reported a 103% year-over-year growth in bookings, with a bookings run rate of $1.1 billion as of the end of 2025 [4] - The company has 2.5 million members and is now operating cash flow positive [4] Market Position and Competition - Whoop's valuation places it just below competitors Shield AI and Kraken, which are valued at $10.4 billion and $10.5 billion respectively [4] - The company is viewed as a key player in the growing longevity space, attracting investments from major healthcare institutions [3] Product Innovations - Whoop offers a high-performance fitness wearable that focuses on monitoring physiological data continuously, distinguishing itself from traditional smartwatches [7] - The latest model, Whoop MG, has received FDA clearance for medical-grade ECG and blood pressure monitoring, indicating a shift towards clinical health integration [9] - The platform utilizes Whoop Coach AI to provide personalized training recommendations based on user data [9]

Whoop valuation tops $10B, setting up highly anticipated IPO Proactive uses images sourced from Shutterstock Boston-based wearable company Whoop has raised $575 million in new funding, boosting its valuation to over $10 billion, roughly three times what it was four years ago, the company said. The company, which tracks biometric data to optimize performance and recovery, has more than 2.5 million members and grew bookings by 103% year-over-year. It ended 2025 with a bookings run rate of $1.1 billion an ...

Core Insights - Whoop has raised $575 million in Series G funding, achieving a valuation of $10.1 billion, indicating strong investor confidence in the wearable device market [1] - The company has 2.5 million members and reported a 103% year-over-year growth in bookings, with a run rate of $1.1 billion [4] Funding Details - The Series G funding round was led by Collaborative Fund and included participation from various notable investors such as Qatar Investment Authority, Mubadala Investment Company, and prominent athletes like Cristiano Ronaldo and LeBron James [2] - This funding round positions Whoop just below other high-valued companies like Shield AI and Kraken, reflecting its growing market presence [3] Product and Business Model - Whoop offers a high-performance fitness wearable that focuses on monitoring physiological data without a screen, differentiating itself from traditional smartwatches [5] - The latest model, Whoop MG, has received FDA clearance for medical-grade ECG and blood pressure monitoring, enhancing its clinical health integration [6] - The company's subscription-based model includes the strap at no upfront cost, with an annual membership priced at $239 as of early 2026 [6]

Whoop (WHOO.PVT) doesn't appear to be running toward an IPO, but it got another healthy injection of capital. The wearable device company — which dubs itself a "human performance company" — said Tuesday it raised $575 million in Series G funding at a $10.1 billion valuation. Rival Oura Health, the maker of the Oura Ring, completed a $140 million Series G funding round at a $1.6 billion valuation last March. The latest round for Whoop was led by Collaborative Fund and includes participation from 2PointZ ...

Group 1 - The company is valued at $10 billion and is attracting everyday health enthusiasts alongside elite athletes like LeBron James and Cristiano Ronaldo as investors [1]

Heidelberg, Germany, March 25, 2026 (GLOBE NEWSWIRE) -- ZenoWell, a wearable neurotechnology company focused on ear-based vagus nerve stimulation solutions, today announced a cooperation with USound, global leader in miniaturized audio systems built on MEMS technology, to explore the integration of USound’s advanced sensing technologies for next-generation wearable devices. ZenoWell develops wearable devices designed to support sleep quality, stress relief, and overall nervous system balance through non-in ...

Financial Data and Key Metrics Changes - In Q4 2025, revenue rose to $85.2 million, up 43% year-over-year, reaching the upper end of guidance [11] - For the full year 2025, revenue was $183 million, representing a 41.8% year-over-year growth [11] - Gross margin in Q4 reached 40.4%, an increase of 3.6 percentage points compared to the same period in 2024 [12][13] - Full-year gross margin for 2025 was 38.3%, with expectations for continued improvement in 2026 [14] Business Line Data and Key Metrics Changes - Amazfit branded product revenue grew 51% year-over-year for the full year 2025, with Q4 sales increasing by 45.4% year-over-year [4][11] - The launch of new products like Active Max and T-Rex Ultra 2 contributed to the strong performance across both entry-level and premium segments [5][10] Market Data and Key Metrics Changes - The company reported strong execution during critical sales periods, particularly Black Friday and Christmas, enhancing brand visibility across major e-commerce channels [11] - The average selling price of products has steadily increased, providing a competitive edge against rivals [22] Company Strategy and Development Direction - The company is transitioning from a traditional wearable hardware business to a hybrid training platform, focusing on integrating hardware, training intelligence, and software [4] - Strategic partnerships with elite athletes and events like HYROX are aimed at enhancing brand credibility and visibility in the performance sports community [8][9] - Plans for 2026 include strengthening the premium product lineup and expanding the ecosystem through AI-driven training insights [10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in sustained demand beyond seasonal trends, projecting Q1 2026 revenue between $50 million and $55 million, representing a year-over-year growth of 30%-43% [10][22] - The company is navigating macroeconomic challenges, including memory cost inflation, while maintaining a focus on cost management and operational efficiency [21] Other Important Information - The net loss attributed to Zepp Health was $6.4 million in Q4 2025, a significant improvement from an adjusted net loss of $22.5 million in Q4 2024 [18] - Cash equivalents stood at $113 million as of December 31, 2025, reflecting a strong liquidity position [19] Q&A Session Summary Question: How many new products are you planning to launch this year compared to last year? - The company plans to launch a similar number of products as last year, which was around nine [26] Question: How are you preparing for the recent spike in the U.S. dollar? - The company is not significantly affected by dollar fluctuations, as production is diversified across Asia, and the dollar is providing some tailwind [28] Question: Which specific areas do you think there are reductions in operating expenses? - Selling and marketing expenses have been front-loaded for product launches, and G&A costs have been decreasing [29]

Zepp Health Earnings Presentation 4Q25 Financial and Operating Results 01 06 4Q25 Revenue and Gross Margin Trend 07 Adjusted Operating Expenses 10 2 Empowering Health, Inspiring Joy Fourth Quarter and Full Year 2025 Investor Relations 15 March 2026 Table of Contents 02 FY25 Financial and Operating Results 03 Revenue 04 4Q25 Gross Margin 05 Business Outlook FY25 Gross Margin 08 Net Income/ Earnings Performance Liquidity Position 09 4Q25 Financial and Operating Results $85.2 Million Revenue -$6.4 Million Adju ...

Core Insights - Indian entrepreneur Deepinder Goyal has completed a $54 million funding round for his wearable device startup Temple, following his resignation as CEO of Zomato and its parent company Eternal [1][2] - The funding round was led by Goyal himself, with participation from Steadview Capital and other notable investors, including founders of major Indian tech companies [2][3] - Temple aims to develop high-performance wearable devices for elite athletes, focusing on monitoring brain blood flow through sensors worn on the temple [3][4] Funding Details - The funding round raised $54 million, equivalent to approximately 371 million RMB, with a post-money valuation of about $190 million, or approximately 1.305 billion RMB [1][2] - Over 30 employees participated in the investment at the same valuation, indicating strong internal support for the venture [1] Company Background - Goyal co-founded Zomato in 2008, which has become one of India's largest food delivery platforms, and he recently transitioned leadership to Albind Singh Dhingra [2][3] - Temple represents a shift in Goyal's focus towards higher-risk ventures, with a commitment to exploring technologies aimed at extending human lifespan and advancements in defense technology through other investments [4] Strategic Focus - Temple is positioned as a project that reflects Goyal's strategic emphasis on sports performance and health technology, having previously invested in companies like Ultrahuman, which competes with Oura smart rings [4] - The company is actively recruiting talent in embedded systems, computational neuroscience, and brain-machine interface engineering to support its development goals [4]